| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10548-014-0415-1 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s10548-014-0415-1 |
| P932 | PMC publication ID | 4529880 |
| P698 | PubMed publication ID | 25370484 |
| P5875 | ResearchGate publication ID | 267871752 |
| P50 | author | Magda N. Tsolaki | Q57073392 |
| Bruno Vellas | Q66877204 | ||
| Christian Spenger | Q114432264 | ||
| J-Sebastian Muehlboeck | Q114432265 | ||
| Simon Lovestone | Q30582986 | ||
| Iwona Kłoszewska | Q38633661 | ||
| Hilkka Soininen | Q38636823 | ||
| Lars-Olof Wahlund | Q38637441 | ||
| Eric Westman | Q41538282 | ||
| Patrizia Mecocci | Q46713839 | ||
| P2093 | author name string | Andrew Simmons | |
| Wasim Khan | |||
| Nigel Jones | |||
| AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging Initiative | |||
| P2860 | cites work | OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification | Q58045925 |
| AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease | Q95800564 | ||
| Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease | Q22242926 | ||
| The clinical use of structural MRI in Alzheimer disease | Q24609648 | ||
| Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline | Q24630962 | ||
| The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods | Q24647259 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Cortical Surface-Based Analysis | Q28124697 | ||
| Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease | Q28742333 | ||
| Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria | Q29614408 | ||
| Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain | Q29614725 | ||
| pROC: an open-source package for R and S+ to analyze and compare ROC curves | Q30050695 | ||
| Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies | Q30481978 | ||
| 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. | Q30496583 | ||
| Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models | Q31137205 | ||
| Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. | Q32091544 | ||
| Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment | Q33406823 | ||
| Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields | Q33575225 | ||
| Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates | Q33591798 | ||
| Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls | Q33676329 | ||
| Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease | Q33727158 | ||
| Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease | Q34055598 | ||
| Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease | Q34145380 | ||
| Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification | Q34183016 | ||
| Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. | Q34408719 | ||
| Biomarkers in brain disease. Preface. | Q48411055 | ||
| Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study. | Q48484542 | ||
| MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease | Q48548576 | ||
| Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. | Q48840109 | ||
| Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease. | Q48861099 | ||
| Sex differences in the clinical manifestations of Alzheimer disease pathology. | Q48866213 | ||
| AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. | Q49041459 | ||
| Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression. | Q50784497 | ||
| The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. | Q51824464 | ||
| Sequence-independent segmentation of magnetic resonance images. | Q51985867 | ||
| A hybrid approach to the skull stripping problem in MRI. | Q51995443 | ||
| Hippocampal neurons in pre-clinical Alzheimer's disease. | Q53263608 | ||
| Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. | Q53292472 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Multimodal classification of Alzheimer's disease and mild cognitive impairment | Q34672813 | ||
| Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment | Q34733398 | ||
| Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides | Q35010843 | ||
| Mild cognitive impairment: differential atrophy in the hippocampal subfields | Q35707941 | ||
| Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment | Q36508436 | ||
| An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment. | Q36707577 | ||
| Automatic classification of MR scans in Alzheimer's disease | Q36965246 | ||
| Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. | Q37111598 | ||
| MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change | Q37273569 | ||
| Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. | Q37337866 | ||
| Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion | Q39618253 | ||
| Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls | Q42905311 | ||
| High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age. | Q43088178 | ||
| MRI measures of Alzheimer's disease and the AddNeuroMed study | Q43497894 | ||
| Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps | Q46086911 | ||
| Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease | Q47671587 | ||
| Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease | Q48246445 | ||
| Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls. | Q48373578 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| mild cognitive impairment | Q1472703 | ||
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 746-759 | |
| P577 | publication date | 2014-11-05 | |
| P1433 | published in | Brain Topography | Q15757692 |
| P1476 | title | Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts | |
| P478 | volume | 28 |
| Q33822745 | APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters |
| Q31142517 | Advanced magnetic resonance imaging of neurodegenerative diseases |
| Q59336905 | Alzheimer's disease: 3-Dimensional MRI texture for prediction of conversion from mild cognitive impairment |
| Q97883015 | Assessment of Alzheimer's Disease Based on Texture Analysis of the Entorhinal Cortex |
| Q91054992 | Characterization of hippocampal subfields using ex vivo MRI and histology data: Lessons for in vivo segmentation |
| Q47992697 | Combining a Patch-based Approach with a Non-rigid Registration-based Label Fusion Method for the Hippocampal Segmentation in Alzheimer's Disease |
| Q92302314 | Differentiating Between Healthy Control Participants and Those with Mild Cognitive Impairment Using Volumetric MRI Data |
| Q93206679 | Discriminating Alzheimer's disease progression using a new hippocampal marker from T1-weighted MRI: The local surface roughness |
| Q38601339 | Entorhinal cortex: a good biomarker of mild cognitive impairment and mild Alzheimer's disease |
| Q104583930 | FreeSurfer-based segmentation of hippocampal subfields: A review of methods and applications, with a novel quality control procedure for ENIGMA studies and other collaborative efforts |
| Q38379615 | Hippocampal formation alterations differently contribute to autobiographic memory deficits in mild cognitive impairment and Alzheimer's disease |
| Q64094583 | Hippocampal subfield CA2+3 exhibits accelerated aging in Alcohol Use Disorder: A preliminary study |
| Q93214027 | In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies |
| Q41693604 | Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly |
| Q92759293 | Longitudinal volume changes of hippocampal subfields and cognitive decline in Parkinson's disease |
| Q58728194 | MRI Asymmetry Index of Hippocampal Subfields Increases Through the Continuum From the Mild Cognitive Impairment to the Alzheimer's Disease |
| Q90288676 | Multimodal Hippocampal Subfield Grading For Alzheimer's Disease Classification |
| Q38892045 | Prediction of Cognitive and Functional Decline Using the Telephone-Administered Minnesota Cognitive Acuity Screen. |
| Q42376223 | Prediction of Treatment Response to Donepezil using Automated Hippocampal Subfields Volumes Segmentation in Patients with Mild Alzheimer's Disease. |
| Q38876654 | Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. |
| Q41454666 | Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study |
| Q47618470 | Segmenting hippocampal subfields from 3T MRI with multi-modality images |
| Q91625829 | Soluble Aβ Oligomers Impair Dipolar Heterodendritic Plasticity by Activation of mGluR in the Hippocampal CA1 Region |
| Q89971040 | Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment |
| Q49594142 | The association between hippocampal subfield volumes and education in cognitively normal older adults and amnestic mild cognitive impairment patients. |
| Q57467639 | The lifespan Human Connectome Project in aging: An overview |
| Q47665469 | The relevance of hippocampal subfield integrity and clock drawing test performance for the diagnosis of Alzheimer's disease and mild cognitive impairment. |
| Q96962661 | Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases |
Search more.